Delivery Order SPE2DB22D3501-SPE2DB25FXA04
- Not listed
- The Defense Logistics Agency awarded a $1,303.20 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Epinephrine 1 mg/10 mL Luerjet auto-injectors in 10 mL quantities, with a completion date of August 8, 2025. This contract utilizes firm fixed pricing and represents a non-set-aside, competitively awarded procurement. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Epinephrine 1 mg/10 mL LuerJet auto-injectors with a contract ceiling value of $2,953.92 and an ultimate completion date of June 30, 2025. This competitive award, issued under a firm fixed-price delivery order arrangement with no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Epinephrine 1 mg/10 mL LuerJet auto-injectors with a ceiling value of $1,430.04. This non-competitive delivery order is scheduled for completion by January 5, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract utilizes firm fixed pricing and represents a standard procurement under the company's broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,105.47 to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/10 mL Luerjet 10 mL auto-injectors. This non-competitive, firm fixed-price delivery order was awarded on November 25, 2025, with an ultimate completion date of November 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/10 ml LuerJet auto-injectors on July 31, 2025, with an ultimate completion date of August 1, 2025. The contract, valued at $2,412.40, is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,333.86 to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/10 mL LuerJet auto-injectors on a firm fixed price basis. The award was made on December 11, 2025, with an ultimate completion date of December 12, 2025, and represents a non-competitive delivery order. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,508.05 to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/10 mL LuerJet auto-injectors on June 4, 2025, with an ultimate completion date of June 5, 2025. This non-competitive delivery order utilizes a firm fixed-price structure and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The product will be delivered to the company's corporate...
- The Defense Logistics Agency awarded a $1,214.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Epinephrine 1 mg/10 mL Luerjet auto-injectors on September 17, 2025, with completion targeted for September 18, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award carried no set-aside designation and was...
- The Defense Logistics Agency awarded a delivery order valued at $1,260.33 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Epinephrine 1 MG/10 ML Luerjet 10ML auto-injectors. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. This delivery order is executed...
- The Defense Logistics Agency awarded a delivery order valued at $2,455.95 to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/10 ml Luerjet 10ml auto-injectors. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement with an ultimate completion date of September 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, fulfilling...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXA04Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,404.34 to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/10 ml LuerJet 10ml auto-injectors. This contract was competitively awarded without set-aside designation and carries an ultimate completion date of August 26, 2025. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. The award utilizes firm fixed pricing under a delivery order contract type, reflecting DLA's standard procurement approach for pharmaceutical commodities supporting military and federal healthcare operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply an extensive range of pharmaceuticals and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's role as a major pharmaceutical distributor and critical federal medical procurement vendor positions it as a key provider within DLA's Medical Supply Chain serving defense healthcare requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 8/25/25 |